| Metric | შპს ნეოფარმი | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾19.2m₾15.4m | ₾2.70bn₾2.32bn |
| Revenue growth | 25.0% | 16.6% |
| Profitability | ||
| EBITDA | -₾498k-₾1.4m | — |
| EBITDA margin | -2.6%-9.4% | — |
| Net profit | -₾589k-₾1.5m | ₾1.84bn₾1.33bn |
| Net margin | -3.1%-9.5% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾8.0m₾8.5m | ₾39.27bn₾31.39bn |
| Total equity | ₾5.1m₾6.1m | ₾5.63bn₾4.45bn |
| ROE | -11.6%-23.8% | 32.6%30.0% |